XML 88 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Mar. 24, 2013
Mar. 25, 2012
Cash and cash equivalents at beginning of year $ 10,886 $ 27,490
Operating activities:    
Net income (loss) including non-controlling interest 5,439 (221)
Adjustments to reconcile net income (loss) including non-controlling interest to net cash provided by operating activities:    
Equity in earnings of unconsolidated affiliates (6,712) (14,166)
Dividends received from unconsolidated affiliates 10,531 4,150
Depreciation and amortization expense 19,263 20,384
Loss on extinguishment of debt 1,102 462
Loss on previously held equity interest   3,656
Non-cash compensation expense 1,896 2,070
Deferred income taxes 4,703 (505)
Other 300 239
Changes in assets and liabilities, excluding effects of foreign currency adjustments:    
Receivables, net 2,094 (4,009)
Inventories 4,460 16,784
Other current assets and income taxes receivable 564 (859)
Accounts payable and accrued expenses 1,756 (1,574)
Income taxes payable (470) 843
Net cash provided by operating activities 44,926 27,254
Investing activities:    
Capital expenditures (4,522) (5,329)
Investments in unconsolidated affiliates   (360)
Other investments (1,835)  
Proceeds from other investments 592  
Acquisition, net of cash acquired   (356)
Proceeds from sale of assets 56 224
Other (272) 14
Net cash used in investing activities (5,981) (5,807)
Financing activities:    
Payments of notes payable   (10,288)
Proceeds from revolving credit facilities 64,100 95,600
Payments on revolving credit facilities (63,800) (95,200)
Payments on term loans (26,530)  
Proceeds from related party term loan 1,250  
Repurchase and retirement of common stock (9,671)  
Contributions from non-controlling interest 880 320
Other (76) (442)
Net cash used in financing activities (33,847) (10,010)
Effect of exchange rate changes on cash and cash equivalents (83) (3,107)
Net increase in cash and cash equivalents 5,015 8,330
Cash and cash equivalents at end of period $ 15,901 $ 35,820